Treatment Information

Back

Non-Hodgkin's Lymphoma treatment details. Immunotherapy.

Seoul National University, Seoul, Korea.

Survival: monthsCountry:Korea
Toxiciy Grade:5City/State/Province:Seoul
Treatments:ImmunotherapyHospital:Seoul National University
Drugs:Journal:Link
Date:Dec 2011

Description:

Patients:
This study involved 38 non-Hodgkin lymphoma patients who had previously received chemotherapy and autologous stem cell transplant. The median patient age was 37 years and 68.4% were male.

Treatment:
Patients received an allogeneic stem cell transplant (stem cells collected from another person).

Toxicities:
Treatment-related deaths due to graft versus host disease, systemic infection, and liver failure were reported.

Results:
The median overall survival was 19 months.

Correspondence: Dr. Sung-Soo Yoon; email: [email protected]



Back